28 Jan Atalanta Therapeutics
/ PORTFOLIO Boston, MAAtalanta Therapeutics is a biotechnology company dedicated to finding solutions for intractable diseases of the central nervous system. Utilizing its novel platform of divalent small interfering RNA (di-siRNA), Atalanta is initially focused on advancing two lead programs through clinical proof-of-concept: KCNT1 (ATL-201) to...